Form 4: Merck Director Acquires Phantom Stock Units

A Merck & Co. director, Surendralal L. Karsanbhai, acquired phantom stock units equivalent to 552.8749 shares of common stock.

Summary

• Surendralal L. Karsanbhai, a director at Merck & Co., acquired 552.8749 phantom stock units on January 1, 2025.
• These phantom stock units are equivalent to 552.8749 shares of Merck common stock.
• The phantom stock units will be settled in cash upon the director's termination of service, according to a distribution schedule.
• The price of the phantom stock units is based on the closing price of Merck common stock on the business day prior to the director's service date, which was $99.48 per share.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with the company's performance.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service.

Industry Context

This is a standard practice for director compensation, aligning their interests with the company's performance.

Comparison to Industry Standards

• Phantom stock grants are a common form of equity compensation for directors in large public companies like Merck.
• Many companies use similar methods to align director compensation with shareholder value.
• The vesting and settlement terms are typical for these types of grants, often tied to service duration and termination.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

phantom stock, director, Merck, stock units, equity, compensation